Literature DB >> 7080947

Concentration effect relationships of infused histamine in normal volunteers.

P W Ind, M J Brown, F J Lhoste, I Macquin, C T Dollery.   

Abstract

Histamine was infused in six normal volunteers at rates of 16, 32, 64 and 96 ng/kg/min increasing at 5-min intervals followed by 128 ng/kg/min for 45 min. Heart rate increased, diastolic blood pressure decreased and skin temperature increased in a dose-dependent fashion. Mean heart rate increased by 15.6 +/- 5.7 beats/min, mean diastolic pressure fell by 8.8 +/- e.2 mmHg and mean skin temperature increased by 1.2 +/- 0.3 degrees C at the highest infusion rate. Mean plasma histamine rose from a basal level of 0.20 +/- 0.03 ng/ml to 1.97 +/- 0.25 ng/ml at the end of the highest infusion rate. The threshold infusion rate for physiological effects was 64-96 ng/kg/min corresponding to 0.77-0.97 ng/ml. Salivary flow was stimulated by 21% after 30 min at the highest dose infusion (P = 0.05). Plasma adrenaline increased 132% but plasma noradrenaline was unchanged. There was a linear decline in heart rate after terminating the histamine infusion with a half time of 82 sec. The half life of infused histamine in the plasma was 102 sec. The clearance of histamine from the plasma was 6.1 %/- 0.2 l/min or 83 ml/kg/min. These concentration effect relationships in normals throw doubt on some of the high endogenous plasma histamine values in the literature.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7080947     DOI: 10.1007/BF01965099

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  17 in total

1.  Effects of histamine on human isolated heart muscle: comparison with effects of noradrenaline.

Authors:  R W Gristwood; J C Lincoln; D A Owen
Journal:  J Pharm Pharmacol       Date:  1980-02       Impact factor: 3.765

Review 2.  Histamine release in clinical conditions.

Authors:  W Lorenz; A Doenicke
Journal:  Mt Sinai J Med       Date:  1978 May-Jun

3.  Venous plasma histamine in exercise- and hyperventilation-induced asthma in man.

Authors:  P J Barnes; M J Brown
Journal:  Clin Sci (Lond)       Date:  1981-08       Impact factor: 6.124

4.  Platelet histamine.

Authors:  M J Brown; P W Ind; D A Jenner
Journal:  N Engl J Med       Date:  1980-09-25       Impact factor: 91.245

5.  Histamines, basophils and eosinophils in severe asthma.

Authors:  T J Charles; S J Williams; A Seaton; C Bruce; W H Taylor
Journal:  Clin Sci (Lond)       Date:  1979-07       Impact factor: 6.124

6.  Plasma histamine changes during provoked bronchospasm in asthmatic patients.

Authors:  K N Bhat; C M Arroyave; S R Marney; D D Stevenson; E M Tan
Journal:  J Allergy Clin Immunol       Date:  1976-12       Impact factor: 10.793

7.  Novel double-isotope technique for enzymatic assay of catecholamines, permitting high precision, sensitivity and plasma sample capacity.

Authors:  M J Brown; D A Jenner
Journal:  Clin Sci (Lond)       Date:  1981-11       Impact factor: 6.124

8.  H1 + H2-receptor antagonists for premedication in anaesthesia and surgery: a critical view based on randomized clinical trials with Haemaccel and various antiallergic drugs.

Authors:  W Lorenz; A Doenicke; B Schöning; J Mamorski; D Weber; E Hinterlang; B Schwarz; E Neugebauer
Journal:  Agents Actions       Date:  1980-04

9.  Measurement of histamine: a quality control study.

Authors:  G J Gleich; W M Hull
Journal:  J Allergy Clin Immunol       Date:  1980-10       Impact factor: 10.793

10.  Epinephrine plasma metabolic clearance rates and physiologic thresholds for metabolic and hemodynamic actions in man.

Authors:  W E Clutter; D M Bier; S D Shah; P E Cryer
Journal:  J Clin Invest       Date:  1980-07       Impact factor: 14.808

View more
  12 in total

1.  Plasma histamine and clinical tolerance to infused histamine in normal, atopic and urticarial subjects.

Authors:  I Pollock; R D Murdoch; M H Lessof
Journal:  Agents Actions       Date:  1991-03

2.  Systemic mast cell degranulation increases mortality during polymicrobial septic peritonitis in mice.

Authors:  Eric J Seeley; Rachel E Sutherland; Sophia S Kim; Paul J Wolters
Journal:  J Leukoc Biol       Date:  2011-06-07       Impact factor: 4.962

Review 3.  Adverse effects of nondepolarising neuromuscular blocking agents. Incidence, prevention and management.

Authors:  M Abel; W J Book; J B Eisenkraft
Journal:  Drug Saf       Date:  1994-06       Impact factor: 5.606

4.  Plasma histamine in asthmatic and control subjects following exercise: influence of circulating basophils and different assay techniques.

Authors:  D J Morgan; I Moodley; M J Phillips; R J Davies
Journal:  Thorax       Date:  1983-10       Impact factor: 9.139

5.  Local histamine release after immunological and non-immunological mast cell degranulation in vivo.

Authors:  P W Ind; A Miyatake; D J Heavey; C T Dollery
Journal:  Agents Actions       Date:  1984-04

6.  Clearance of histamine from the peritoneal cavity of rats.

Authors:  E Kownatzki
Journal:  Agents Actions       Date:  1984-10

7.  Assessment of the effects of contingent histamine injections on the reinforcing effectiveness of cocaine using behavioral economic and progressive-ratio designs.

Authors:  Kevin B Freeman; Brian C McMaster; Peter G Roma; William L Woolverton
Journal:  Psychopharmacology (Berl)       Date:  2014-01-08       Impact factor: 4.530

8.  Histamine symptoms and histamine metabolism in chronic granulocytic leukaemia.

Authors:  G Granerus; A Weinfeld; J Westin
Journal:  Agents Actions       Date:  1983-04

9.  Mast cell degranulation and de novo histamine formation contribute to sustained postexercise vasodilation in humans.

Authors:  Steven A Romero; Jennifer L McCord; Matthew R Ely; Dylan C Sieck; Tahisha M Buck; Meredith J Luttrell; David A MacLean; John R Halliwill
Journal:  J Appl Physiol (1985)       Date:  2016-08-25

10.  Plasma histamine concentration during propranolol induced bronchoconstriction.

Authors:  P W Ind; P J Barnes; M J Brown; C T Dollery
Journal:  Thorax       Date:  1985-12       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.